29. Results of postoperative radiotherapy in Low-Grade Gliomas  by Kępka, L. et al.
Centrum Onkologii - Instytut, Warszawa.
L. Kepka, J. Fijuth, C. Leszczyk,
K. Oyttus-Cebulok, A. Żółciak
Purpose: To evaluate results, prognostic
tactors and patterns ot tailure ot the
postoperative radiotherapy (PRT) tor Low-Grade
Gliomas (LGG).
Methods:· Setween 1985 and 1995, 158
patients with LGG (WHO II) received PRT.
There .were 116 astrocytomas, 17 mixed
oligoastrocytomas, 25 oligodendrogliomas.
Median age was 39 years (range: 17-74).
Conventional treatment techniques and doses
were employed (median total dose- 58 Gy,
median dose per traction - 2 Gy). Ali known
parameters with possible intluences on
prognosis were analysed in univariate analysis
(UA). Then a multivariate analysis (MA) was
performed tor variabies with significance level
p<0.2 in UA. CT seans taken prior to initial
surgery and at the time ot recurrence have been
compared to define the recurrence pattern in
relation to the initial tumour site. Initial and
recurrent tumour were drawn in the simulator
films in order to precise the tailure pattern in
relation to irradiated volume. Survival after
recurrence (SAR) was analysed using Kaplan-
Meier method and prognostic tactors were
analysed using logrank test.
Results: The minimum tollow-up period tor
alive patient was 52 months. The 5- and 10-year
actuarial overall survival rate were 55- and 41 %
respectively. The actuarial progression tree
survival rate were 48% and 29% tor 5 and 10
years respectively. MA revealed that good WHO
performance status (p=0.00001), duration ot
symptoms betore treatment >12 months
(p=0.00003), seizures at presentation
(p=0.0001), age < 45 years (p=0.01) and gross
total resection (p=O.03) are associated with
increased survival.
Median time to recurrence was 49.5 months
(range: 1-134). The precise localisation ot
recurrence was possible in 69 pts (73%). Ali but
three pts recurred within the initial tumour
margin. Two ot them recurred at 1-3 cm ot the
initial tumour margin, one recurred at distance,
in the controlateral hemisphere. The last one
was the only case ot recurrence outside the
previously irradiated volume. Median SAR was 8
Palliative irradiation is given to about 40% ot
cancer patients receiving radiotherapy. The
large number ot patients stand in sharp contrast
to the scarce number ot publications related to
this type ot cancer therapy. It is necessary to
emphasize that palliative radiotherapy should be
administered according to the different principles
than curative treatment. The general principles
governing palliative use ot irradiation, detined by
R. Paterson in 1956, seem to be still valid,
However, since that time a substantial progress
has been made. The main elements ot this
progress, and the main directions of research
are related to:
1. optimisation ot tractionation schedules
/including hyperfractionation/;
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months (range: 0.5-43). Intormation about
treatment ot recurrence was available in 76 pts
(81 %) - (11 - surgery, 9 - surgery and
chemotherapy, 2 - surgery and radiotherapy, 8
- surgery, radiotherapy and chemotherapy, 1 -
radiotherapy, 19 - chemotherapy, 26 -
supportive care). There was no correlation
between any treatment method and patient
related parameters in the Spearman's rank test.
In univariate analysis only addition ot
chemotherapy to recurrence management
(p=O.001) and duration ot symptoms betore
initial surgery >12 months (p=O.004) were
associated with increased SAR. Surgery at
recurrence and patient related parameters (age,
performance status, neurologie function,
seizures) did not intluence survival.
Conclusions: Long-term results ot the
treatment were unfavorable tor a majority of
patients with LGG. Good WHO performance
status, duration ot symptoms betore treatment
>12 months, seizures at presentation, age < 45
years and gross total resection are associated
with increased survival. Our data contirm that
Iimited-volume irradiation tor LGG is an
adequate approach. Management ot tailures
after PRT ot brain tumours remains a
therapeutic challenge. Our results show that
chemotherapy at recurrence signiticantly
improves survival. Surgery was not effective
treatment at recurrence.
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